Both Carboplatin and Bevacizumab Improve Pathological Complete Remission Rate in Neoadjuvant Treatment of Triple Negative Breast Cancer: A Meta-Analysis

Triple negative breast cancer (TNBC) is associated with high pathological complete remission (pCR) rate in neoadjuvant treatment (NAT). TNBC patients who achieve pCR have superior outcome than those without pCR. A meta-analysis was done to evaluate whether integrating novel approaches into NAT can i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiao-song, Yuan, Ying, Garfield, David H., Wu, Jia-yi, Huang, Ou, Shen, Kun-wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172579/
https://www.ncbi.nlm.nih.gov/pubmed/25247558
http://dx.doi.org/10.1371/journal.pone.0108405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172579/
https://www.ncbi.nlm.nih.gov/pubmed/25247558
http://dx.doi.org/10.1371/journal.pone.0108405

Ejemplares similares